Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
TherapeuticsMD
TXMD
$25M
| $43.6K | ﹤0.01% |
19,719
+9,013
| +84% | +$18.6K |
|
3202
Siebert Financial
SIEB
$104M
| $43.5K | ﹤0.01% |
26,299
-8,542
| -25% | -$15.5K |
|
3203
Bridger Aerospace
BAER
$60M
| $43.5K | ﹤0.01% |
22,642
-62,546
| -73% | -$124K |
|
3204
Natural Health Trends
NHTC
$13.9M
| $40.8K | ﹤0.01% |
23,075
-4,222
| -15% | -$11.1K |
|
3205
SCYNEXIS
SCYX
$45.8M
| $40.8K | ﹤0.01% |
+10,020
| New | +$62.2K |
|
|
CYCN
3206
DELISTED
Cyclerion Therapeutics
CYCN
| $39.7K | ﹤0.01% |
+11,724
| New | +$38K |
|
3207
Kiora Pharmaceuticals
KPRX
$11.7M
| $31.9K | ﹤0.01% |
+12,138
| New | +$30.5K |
|
|
FLNA
3208
Filana Therapeutics
FLNA
$34.7M
| $31K | ﹤0.01% |
25,900
-214,006
| -89% | -$305K |
|
3209
Fuel Tech
FTEK
$54.6M
| $29.1K | ﹤0.01% |
13,428
-6,000
| -31% | -$8.91K |
|
3210
Blink Charging
BLNK
$77.5M
| $27.4K | ﹤0.01% |
42,819
| – | – |
|
3211
RLX Technology
RLX
$2.14B
| $27K | ﹤0.01% |
14,223
-346
| -2% | -$718 |
|
3212
Educational Development Corp
EDUC
$11.2M
| $25.7K | ﹤0.01% |
17,047
| – | – |
|
3213
Mobile Infrastructure Corp
BEEP
$117M
| $22.1K | ﹤0.01% |
15,861
-15,731
| -50% | -$31.2K |
|
3214
Battalion Oil
BATL
$74.5M
| $19.3K | ﹤0.01% |
14,691
| – | – |
|
3215
INmune Bio
INMB
$64.7M
| $17.2K | ﹤0.01% |
10,581
| – | – |
|
3216
Metagenomi Therapeutics
MGX
$45M
| $15.2K | ﹤0.01% |
12,797
| – | – |
|
3217
Ring Energy
REI
$396M
| $12.9K | ﹤0.01% |
11,946
-39
| -0.3% | -$54 |
|
|
IMMP
3218
Immutep
IMMP
$48.8M
| $10.9K | ﹤0.01% |
26,109
-4,300
| -14% | -$1.87K |
|
|
UCL
3219
uCloudlink Group
UCL
$15.7M
| $9.7K | ﹤0.01% |
10,461
| – | – |
|
|
VIOT
3220
Viomi Technology
VIOT
$89M
| $7.92K | ﹤0.01% |
10,123
-8,656
| -46% | -$8.34K |
|
3221
Accuray
ARAY
$29.3M
| $4.72K | ﹤0.01% |
18,291
-276,612
| -94% | -$103K |
|
3222
ABVC BioPharma
ABVC
$26.7M
| – | – |
-12,227
| Closed | -$11.9K |
|
3223
Achieve Life Sciences
ACHV
$744M
| – | – |
-52,420
| Closed | -$154K |
|
3224
Alset
AEI
$39.3M
| – | – |
-10,184
| Closed | -$18.7K |
|
|
AEVA
3225
Aeva Technologies
AEVA
$1.02B
| – | – |
-58,112
| Closed | -$760K |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.